PillRx only · Suspension · Ophthalmic
Neomycin Sulfate, Polymyxin B Sulfate And Dexamethasone
Brands: Maxitrol · Neomycin And Polymyxin B Sulfates And Dexamethasone · Dexamethasone + Neomycin Sulfate + Polymyxin B Sulfate
4 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US4 NDCs
4 active makers
4 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.608
Latest avg · Jul 22, 2026
-8%
Since Dec 17, 2025
4
Active US suppliers
50%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
42K
Rx · 2026 Q1
215K
Units dispensed
+149%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Harrow Eye, LLC | unknown | 1 | SUPPLYING |
| Sandoz Inc | unknown | 1 | SUPPLYING |
| NuCare Pharmaceuticals, Inc. | unknown | 1 | SUPPLYING |
| Nordic Pharma, Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Oct 17, 2019RECALLRecall (Class III): Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, Rx Only, Sterile, 5 mL bottle, Manufactured …
Labeling: Incorrect or missing package insert. — Recalling firm: Sandoz Inc — Nationwide in the U.S.